AbCellera (ABCL), Everest to Co-Develop New Antibody Therapies

Mohit Chouhan September 24, 2021
AbCellera (ABCL) partners with China-based Everest Medicines to expand the latter???s pipeline across multiple indications.


Post a Comment

0 Comments